Ушбу иш иқтибос қилган ишлар

121 та иш

Иш: Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy

Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Шарҳ мақола20256 иқтибос
ABI
Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets
Atieh Raoufi, Hamed Soleimani Samarkhazan, Sina Nouri +5
Шарҳ мақола20255 иқтибос
ABI
Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53
Leila Rajabi, Mostafa Ebrahimdoost, Seyed Amin Mohammadi +3
Мақола20255 иқтибос
ABI
Role of Precision Medicine and Personalized Medicine in the Treatment of Diseases
Mehrdad Farrokhi, Fatemeh Taheri, Parisa Jafari Khouzani +25
Китоб20234 иқтибос
ABI
Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis
Aziz Kubaev, Fadhil Faez Sead, Mohammad Pirouzbakht +6
Шарҳ мақолаExtracellular vesicles in diseaseJournal of Liposome Research20254 иқтибос
ABI
Aptamers used for biosensors and targeted therapy
Yi Ning, Jue Hu, Fangguo Lu
Шарҳ мақола20203 иқтибос
ABI
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon
Шарҳ мақола20183 иқтибос
ABI
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Tatsuo Adachi, Yoshikazu Nakamura
Шарҳ мақола20193 иқтибос
ABI
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel, Dirk Zboralski, Christian Maasch +5
Мақола20132 иқтибос
ABI
Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40
Elizabeth D. Pratico, Bruce A. Sullenger, Smita K. Nair
Мақола20122 иқтибос
ABI
Aptamers and aptamer targeted delivery
Amy Yan, Matthew Levy
Шарҳ мақола20092 иқтибос
ABI
Aptamers: current challenges and future prospects
Guido Tomás Rozenblum, Vanina Gisela Lopez, Alfredo Daniel Vitullo +1
Шарҳ мақола20152 иқтибос
ABI
Aptamers: A promising chemical antibody for cancer therapy
Gang Zhou, George D. Wilson, Lionel Hebbard +4
Шарҳ мақола20162 иқтибос
ABI
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou, John J. Rossi
Шарҳ мақола20162 иқтибос
ABI
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
Shuaijian Ni, Zhenjian Zhuo, Yufei Pan +12
Шарҳ мақола20202 иқтибос
ABI
Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents
Prabir Kumar Kulabhusan, Babar Hussain, Meral Yüce
Шарҳ мақола20202 иқтибос
ABI
Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy
Jing Han, Liang Gao, Jinsheng Wang +1
Шарҳ мақола20202 иқтибос
ABI
Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
Kaylin G. Earnest, Erin M. McConnell, Eman M. Hassan +8
Мақола20212 иқтибос
ABI
Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy
Yue Lang, Yanan Lyu, Yehui Tan +1
Шарҳ мақола20232 иқтибос
ABI
Von Willebrand disease (VWD) and pregnancy: a comprehensive overview
Hamed Soleimani Samarkhazan, Mohammad Navid Khaksari, Ali Rahmati +3
Шарҳ мақола20252 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI